- Home
- VYNE vs ICMB Comparison
VYNE vs ICMB Comparison
Compare VYNE & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- ICMB
- Stock Information
- Founded
- VYNE 2003
- ICMB 2012
- Country
- VYNE United States
- ICMB United States
- Employees
- VYNE N/A
- ICMB N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- VYNE Health Care
- ICMB Finance
- Exchange
- VYNE Nasdaq
- ICMB Nasdaq
- Market Cap
- VYNE 35.7M
- ICMB 41.1M
- IPO Year
- VYNE 2018
- ICMB N/A
- Fundamental
- Price
- VYNE $0.94
- ICMB $2.69
- Analyst Decision
- VYNE Strong Buy
- ICMB
- Analyst Count
- VYNE 2
- ICMB 0
- Target Price
- VYNE $6.25
- ICMB N/A
- AVG Volume (30 Days)
- VYNE 259.3K
- ICMB 45.7K
- Earning Date
- VYNE 05-08-2025
- ICMB 05-13-2025
- Dividend Yield
- VYNE N/A
- ICMB 17.81%
- EPS Growth
- VYNE N/A
- ICMB N/A
- EPS
- VYNE N/A
- ICMB 0.82
- Revenue
- VYNE $605,000.00
- ICMB $20,996,189.00
- Revenue This Year
- VYNE N/A
- ICMB N/A
- Revenue Next Year
- VYNE N/A
- ICMB N/A
- P/E Ratio
- VYNE N/A
- ICMB $3.27
- Revenue Growth
- VYNE 43.03
- ICMB N/A
- 52 Week Low
- VYNE $0.95
- ICMB $2.46
- 52 Week High
- VYNE $4.30
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- VYNE 25.37
- ICMB 39.62
- Support Level
- VYNE $0.96
- ICMB $2.76
- Resistance Level
- VYNE $1.09
- ICMB $2.82
- Average True Range (ATR)
- VYNE 0.08
- ICMB 0.12
- MACD
- VYNE -0.01
- ICMB -0.02
- Stochastic Oscillator
- VYNE 3.42
- ICMB 11.27
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.